Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1989; 62(02): 648-650DOI: 10.1055/s-0038-1646876 Review Article Schattauer GmbH Stuttgart Biologicals, Standards and Heparin Authors Author Affiliations Duncan P Thomas The National Institute for Biological Standards and Control, Potters Bar, Herts., U.K. Recommend Article Abstract PDF Download(opens in new window) Buy Article(opens in new window) PDF (1756 kb) References References 1 Dale HH. Letter written in 1960 describing the first meeting on international standards in Geneva in 1925. NIBSC archives. 2 Finney D. Statistical Method in Biological Assay. 3rd edition Charles Griffin; 1978 3 Macintosh FC. The biological standardization of heparin. Bull Health Org, League of Nations 1943; 1944; 10: 144-154 4 Thomas DP, Curtis AD, Barrowcliffe TW. A collaborative study designed to establish the 4th International Standard for heparin. Thromb Haemostas 1984; 52: 148-153 5 Petitou M, Duchaussoy P, Lederman I, Choay J, Jacquinet JC, Sinay P, Torri G. Synthesis of heparin fragments: a methyl alpha-pentaside with high affinity for antithrombin III. Carbohyd Res 1987; 167: 67-75 6 Ofosu FA, Danishefsky I, Hirsh J. (eds) Heparin and related polysaccharides: Structure and activities. Ann NY Acad Sci 1989; 556 7 Barrowcliffe TW, Curtis AD, Tomlinson TP, Hubbard AR, Johnson EA, Thomas DP. Standardization of low molecular weight heparins: a collaborative study. Thromb Haemostas 1985; 54: 675-679 8 Barrowcliffe TW, Curtis AD, Johnson EA, Thomas DP. An international standard for low molecular weight heparin. Thromb Haemostas 1988; 60: 1-7 9 Fareed J, Hoppensteadt D, Walenga JM, Huan X, Messmore HL. Validity of the newly established low molecular weight heparin standard in cross referencing low molecular weight heparins. Haemo stasis 1988; 18: 33-47 10 Miles AA, Perry WL. Biological potency and its relation to therapeutic efficacy. Bull World Health Org 1953; 9: 1-14 11 Kakkar VV, Djazaeri B, Fok J, Fletcher M, Scully MF, Westwick J. Low molecular weight heparin and prevention of postoperative deep vein thrombosis. Br Med J 1982; 284: 375-379 12 Roller M, Schoch U, Buchmann P, Largiadèr F, von Felten A, Frick PG. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized double-blind study versus unfractionated heparin. Thromb Haemostas 1986; 56: 243-246
